PRAX - Praxis Precision Medicines Inc
Praxis Precision Medicines Inc Logo

PRAX - Praxis Precision Medicines Inc

https://praxismedicines.com
Hold Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
As of 2025-09-10 (Snapshot)

Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. The company is headquartered in Cambridge, Massachusetts.

52W High
$91.83
52W Low
$26.70
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
2.62
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-6.86
EV/Revenue (<3 favorable)
88.28
P/S (TTM) (<3 favorable)
126.98
P/B (<3 favorable)
2.44
Ownership
Institution‑heavy
Source: Overview
Insiders (1–5% typical)
0.16%
Institutions (25–75% balanced)
120.49%
Shares Outstanding
21,045,800
Float
15,644,600
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
7,765,000
Gross Profit (TTM)
-214,216,000
EPS (TTM)
-12.40
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
-34.98%
ROE (TTM) (>15% strong)
-0.61%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
13.49
Momentum
Bearish momentum
Value
-3.0035
Previous
-2.6378
Trend
Falling
Signal Cross
No cross
As of
Sep. 12, 2025